Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 39.60
-0.40 (-1.00%)
May 16, 2025, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 21.52 billion as of May 16, 2025. Its market cap has increased by 163.65% in one year.
Market Cap
21.52B
Enterprise Value
24.54B
Revenue
6.09B
Ranking
n/a
PE Ratio
24.65
Stock Price
39.60
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has decreased from 26.66B to 21.52B, a decrease of -19.27%. That is a compound annual growth rate of -3.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 193.02B |
| Hansoh Pharmaceutical Group Company | 139.43B |
| JD Health International | 129.52B |
| WuXi Biologics | 95.65B |
| Alibaba Health Information Technology | 84.43B |
| Innovent Biologics | 84.13B |
| Akeso | 74.95B |
| Sino Biopharmaceutical | 72.47B |